Profile
Maria Dobek is referenced in SEC filings as associated with Janux Therapeutics, Inc. as of May 14, 2026. The filings do not publicly specify her exact role (e.g., officer, director, or other insider) or provide a detailed biography beyond the inclusion in the filing. Janux Therapeutics is a biotechnology company focused on cancer immunotherapies. Given the limited information publicly available from the SEC context, her precise position, background, and achievements remain unconfirmed in widely accessible sources.
| Role | Insider |
|---|
| Notability | 40/100 |
|---|
Board memberships
Frequently Asked Questions
Who is Dobek Maria?
Maria Dobek is referenced in SEC filings as associated with Janux Therapeutics, Inc. as of May 14, 2026. The filings do not publicly specify her exact role (e.g., officer, director, or other insider) or provide a detailed biography beyond the inclusion in the filing. Janux Therapeutics is a biotechnology company focused on cancer immunotherapies. Given the limited information p…
How many SEC Form 4 filings has Dobek Maria submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Has Dobek Maria been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($29K) across all tracked filings.
Where can I see all of Dobek Maria's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.